SEC Form 4 · accession 0001209191-16-113543
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Mendlein
Officer — CEO and Director · Director
Period of report
Apr 5, 2016
Accepted (ET)
Apr 6, 2016 · 7:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 5, 2016 | P | 2,500 | $3.55 | A | 248,471 | D |
Table II — derivative securities
No Table II lines on this filing.